The chemical class of TBX2 inhibitors encompasses a broad spectrum of compounds that indirectly influence the activity of TBX2, a transcription factor involved in various cellular processes. These inhibitors target a range of biochemical pathways and mechanisms, reflecting the complexity of transcription factor modulation. The primary strategy in inhibiting TBX2 is to target signaling pathways that regulate its expression or function, rather than direct interaction with the protein itself. This approach is due to the lack of traditional binding sites on TBX2 for small molecules.
These inhibitors include agents that modify epigenetic markers, such as DNA methylation and histone acetylation, potentially altering TBX2 expression. Others target key signaling pathways, such as PI3K, mTOR, MEK, MAPK, JNK, Wnt, and ROCK, which are crucial in regulating various cellular functions that may intersect with TBX2 activity. By modulating these pathways, these compounds can indirectly influence the regulatory role of TBX2 in cell cycle regulation, development, and differentiation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, may affect TBX2 expression by altering DNA methylation patterns. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, can change chromatin structure and potentially affect TBX2 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Similar to Trichostatin A, a histone deacetylase inhibitor that may alter TBX2 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, can affect various signaling pathways and potentially influence TBX2 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, can alter cell growth pathways that may be associated with TBX2 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor, potentially affecting TBX2 through MAPK/ERK signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, could impact signaling pathways related to TBX2. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, may alter signaling pathways relevant to TBX2 function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, can affect cytoskeletal dynamics, potentially influencing TBX2-related pathways. | ||||||